TrialX
Advanced Filters
I am/have/had
added new label for I am/have/had
more
I am looking for
added new label for I am looking for
more
noise

Lung Disease Clinical Trials

A listing of Lung Disease medical research trials actively recruiting patient volunteers. Search for closest city to find more detailed information on a research study in your area.

Found 953 clinical trials

W WEN-FENG Fang

Application of Serial Body Composition Change for Risk Prediction in Treating Patients With Severe Pneumonia

We hypothesize that serial changes of body composition in patients with pneumonia can help clinician to monitor prognosis. It was associated with underlying immune response.

18 years and older All Phase N/A
J JIN-YUAN SHIH, PhD,MD

Optimal EGFR TKIs Treatment Strategies for Lung Adenocarcinoma Harboring EGFR Exon 19 Deletion Variants

To determine the optimal EGFR TKIs treatment strategies for lung adenocarcinoma harboring EGFR exon 19 deletion variants

20-90 years All Phase N/A
S Shabir A Madhi, MD PhD

Persistence of Immunogenicity Following Reduced PCV Dosing Schedules in South African Children

This study will evaluate the persistence of immunogenicity following a reduced dosing schedule of 10- or 13-valent Pneumococcal Conjugate Vaccine (PCV10, PCV13). This is the follow-up of a randomized controlled trial in which children received a single priming dose of PCV10 or PCV13 (at 6 or 14 weeks of age) …

3-5 years All Phase N/A
S Stephanie Garofalo

Predictors of Severe COVID-19 Outcomes

This is a longitudinal, multi-center, observational study collecting diverse biological measurements and clinical and epidemiological data for the purpose of enabling a greater understanding of the onset of severe outcomes, primarily acute respiratory distress syndrome (ARDS) and/or mortality, in patients presenting to the hospital with suspicion or diagnosis of COVID-19. …

21 years and older All Phase N/A
J Jongmin Lee, M.D.

Impact of Respiratory Virus in Critically Ill Patients With Acute Respiratory Failure

This is an observational study to evaluate the clinical impact of respiratory virus in the patients with acute respiratory failure

19 years and older All Phase N/A
H Harriet CORVOL, MD, PhD

Impacts of the Covid-19 Epidemic and Associated Lockdown Measures on the Management Health and Behaviors of Cystic Fibrosis Patients During the 2020 Epidemic

Impacts of the Covid-19 epidemic and associated lockdown measures on the management, health and behaviors of cystic fibrosis patients during the 2020 epidemic

14 years and older All Phase N/A
C Chuck Moser

A Study of Patients With Chronic Disease

TARGET-RWE is a 10-year, international, longitudinal, observational study of patients with chronic disease designed to specifically address important clinical questions that remain incompletely answered from registration trials. The protocol will follow a master protocol design in which a shared study infrastructure supports progressive development of the registry across the spectrum …

100 years and younger All Phase N/A
F Fausto Biancari, Professor

Outcome of COVID-19 Patients After Extracorporeal Membrane Oxygenation for Acute Respiratory Distress Syndrome

This study aims to investigate outcomes and predictors of outcome after extracorporeal membrane oxygenation (ECMO) therapy for severe acute respiratory syndrome (ARDS) in COVID-19 patients.

100 years and younger All Phase N/A
T Tamara Kriukova

Analysis of Chronic Non-infectious Diseases Dynamics After COVID-19 Infection in Adult Patients

Non-commercial depersonalized multi-centered registry study on analysis of chronic non-infectious diseases dynamics after SARS-CoV-2 infection in adults.

18 years and older All Phase N/A
M Matt A Harvey, MSc

Wessex Asthma Cohort of Difficult Asthma

Asthma is now widely recognised to be a heterogeneous disease. The last two decades have seen the identification of a number of biological targets and development of various novel therapies. Despite this, asthma still represents a significant health and economic burden worldwide. Why some individuals should continue to suffer remains …

18-99 years All Phase N/A

Simplify language using AI